These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5786733)

  • 1. Norepinephrine content of tissues in Doca-hypertensive rats.
    Kazda S; Pohlová I; Bíbr B; Kockova J
    Am J Physiol; 1969 Jun; 216(6):1472-5. PubMed ID: 5786733
    [No Abstract]   [Full Text] [Related]  

  • 2. Accumulation of 3H-noradrenaline in cardiac and smooth muscle of rats with experimental hypertension.
    Kazda S; Bibr B
    Strahlentherapie Sonderb; 1968; 67():376-81. PubMed ID: 4305596
    [No Abstract]   [Full Text] [Related]  

  • 3. Turnover of catecholamines in experimental hypertension.
    Louis WJ
    Circ Res; 1970 Oct; 27():Suppl 2:49-53. PubMed ID: 5506148
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of D- and DL-propranolol on blood pressure and cerebral norepinephrine in rats with DOCA-hypertension.
    Lydtin H; Sommerfeldt H
    Int J Clin Pharmacol; 1972 Nov; 6(4):328-31. PubMed ID: 4641848
    [No Abstract]   [Full Text] [Related]  

  • 5. Abnormal storage of norepinephrine in experimental hypertension in the rat.
    Krakoff LR; de Champlain J; Axelrod J
    Circ Res; 1967 Nov; 21(5):583-91. PubMed ID: 6073557
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats.
    Lee TM; Chen CC; Chang NC
    Clin Sci (Lond); 2012 Oct; 123(7):445-57. PubMed ID: 22507072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overflow of endogenous norepinephrine from PVH nucleus of DOCA-salt hypertensive rats.
    Qualy JM; Westfall TC
    Am J Physiol; 1995 Apr; 268(4 Pt 2):H1549-54. PubMed ID: 7733356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A reduction in the accumulation of H3-norepinephrine in experimental hypertension.
    de Champlain J; Krakoff LR; Axelrod J
    Life Sci; 1966 Dec; 5(24):2283-91. PubMed ID: 5972783
    [No Abstract]   [Full Text] [Related]  

  • 9. The antihypertensive effect of taurine in DOCA-salt rats.
    Fujita T; Sato Y
    J Hypertens Suppl; 1984 Dec; 2(3):S563-5. PubMed ID: 6152784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced induction of gastric carcinogenesis by N-methyl-N'-nitro-N-nitrosoguanidine in deoxycorticosterone acetate-NaCl hypertensive rats and its inhibition by potassium chloride.
    Tatsuta M; Iishi H; Baba M; Taniguchi H
    Cancer Res; 1991 Jun; 51(11):2863-6. PubMed ID: 2032226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure variability, cardiac baroreflex sensitivity and organ damage in experimentally hypertensive rats.
    Wang DS; Xie HH; Shen FM; Cai GJ; Su DF
    Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):545-52. PubMed ID: 16026514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The course of blood pressure and organ changes in rats with DOCA-hypertension].
    Hoida G; Lindt S; Eichenberger E
    Arzneimittelforschung; 1976; 26(11):2003-8. PubMed ID: 1037234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morin attenuates blood pressure and oxidative stress in deoxycorticosterone acetate-salt hypertensive rats: a biochemical and histopathological evaluation.
    Prahalathan P; Kumar S; Raja B
    Metabolism; 2012 Aug; 61(8):1087-99. PubMed ID: 22386933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced contractile sensitivity and vasopressin receptor affinity in DOCA-salt hypertension.
    Bockman CS; Jeffries WB; Pettinger WA; Abel PW
    Am J Physiol; 1992 Jun; 262(6 Pt 2):H1752-8. PubMed ID: 1535757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelium, vasopressin receptors, and resistance to DOCA-salt hypertension.
    Bockman CS; Jeffries WB; Pettinger WA; Abel PW
    Am J Physiol; 1993 Jul; 265(1 Pt 2):H15-21. PubMed ID: 8342627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal cardiac norepinephrine storage in isoproterenol-treated rats.
    Mueller RA; Axelrod J
    Circ Res; 1968 Dec; 23(6):771-8. PubMed ID: 4236181
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of intraventricular and intraspinal 6-hydroxydopamine on blood pressure of DOCA-saline hypertensive rats.
    Kubo T; Hashimoto M
    Arch Int Pharmacodyn Ther; 1979 Mar; 238(1):50-9. PubMed ID: 485704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ouabain as an amplifier of mineralocorticoid-induced hypertension.
    Sekihara H; Yazaki Y; Kojima T
    Endocrinology; 1992 Dec; 131(6):3077-82. PubMed ID: 1446641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in cardiac and hypothalamic noradrenergic activity with taurine in DOCA-salt rats.
    Fujita T; Sato Y; Ando K
    Am J Physiol; 1986 Nov; 251(5 Pt 2):H926-33. PubMed ID: 2877584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in renal and central noradrenergic activity with potassium in DOCA-salt rats.
    Fujita T; Sato Y
    Am J Physiol; 1984 May; 246(5 Pt 2):F670-5. PubMed ID: 6144278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.